These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33057922)

  • 1. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
    Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.
    Antunes MS; Cattelan Souza L; Ladd FVL; Ladd AABL; Moreira AL; Bortolotto VC; Silva MRP; Araújo SM; Prigol M; Nogueira CW; Boeira SP
    Mol Neurobiol; 2020 Jul; 57(7):3027-3041. PubMed ID: 32458386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ; Boshoff EL; Duty S
    Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
    Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
    Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
    Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.
    Zarate SM; Pandey G; Chilukuri S; Garcia JA; Cude B; Storey S; Salem NA; Bancroft EA; Hook M; Srinivasan R
    J Neurochem; 2021 May; 157(3):710-726. PubMed ID: 33354763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
    Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
    Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model.
    Jiang X; Tang P-C ; Chen Q; Zhang X; Fan Y-Y ; Yu BC; Gu X-X ; Sun Y; Ge X-Q ; Zhang X-L
    CNS Neurol Disord Drug Targets; 2019; 18(8):609-620. PubMed ID: 31486758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
    Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
    Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.
    Prajapati SK; Garabadu D; Krishnamurthy S
    Neurotox Res; 2017 May; 31(4):478-492. PubMed ID: 28130746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
    Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B; Jin HJ; Song MY; Wang T; Zhao H
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.